ALMRAlamar Biosciences, Inc.vs its industry peers
A metric-by-metric comparison of Alamar Biosciences, Inc. against Laboratory Analytical Instruments — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
Full peer comparison
Peers: same SEC industry (Laboratory Analytical Instruments)| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALMRThis | $1.9B#6 | — | — | — | — | — | — | — | — | — | — | — |
| A | $37.8B#2 | 26.9x#2 | 5.3x#7 | 5.4x#6 | 6.7%#2 | 1.1%#5 | 21.3%#1 | 18.3%#2 | 16.1%#2 | — | 8.7%#8 | 0.7%#1 |
| ASTC | $16M#10 | 36.1x#4 | 1.3x#3 | 15.9x#8 | -41.2%#13 | -18.7%#6 | -1473.4%#13 | -113.9%#11 | -71.6%#8 | 2#5 | 63.4%#2 | — |
| AVTR | $7.1B#5 | — | 1.3x#2 | 1.1x#3 | -3.4%#9 | -174.5%#11 | -3.8%#7 | -9.5%#7 | -2.7%#7 | 4#2 | -23.6%#9 | — |
| BFNH | — | — | — | — | 9.0%#1 | -163.4%#10 | -261.8%#11 | — | — | — | — | — |
| BIO | — | 49.5x#5 | — | — | 0.7%#5 | 141.2%#2 | 1.8%#5 | 11.1%#3 | 0.5%#3 | — | 14.3%#7 | — |
| BIO.B | — | 49.7x#6 | — | — | 0.7%#5 | 141.2%#2 | 1.8%#5 | 11.1%#3 | 0.5%#3 | — | -34.6%#10 | — |
| BNGO | $13M#11 | — | 0.4x#1 | 0.5x#2 | -7.4%#10 | 76.4%#4 | -116.9%#10 | -70.5%#9 | — | — | -65.5%#11 | — |
| BRKR | $9.2B#4 | — | 3.8x#6 | 2.7x#4 | 2.1%#3 | -107.3%#8 | 2.0%#3 | -0.3%#5 | 0.0%#5 | 3#3 | 39.7%#4 | 0.2%#2 |
| BRKRP | $68.2B#1 | — | 27.8x#10 | 19.9x#9 | 2.1%#3 | -107.3%#8 | 2.0%#3 | -0.3%#5 | 0.0%#5 | 3#3 | — | 0.0%#3 |
| CTKB | $597M#8 | — | 1.8x#4 | 3.0x#5 | 0.5%#7 | -1005.3%#13 | -20.0%#8 | -20.3%#8 | — | — | 29.9%#6 | — |
| EYPT | $1.2B#7 | — | 5.4x#8 | 39.3x#10 | -27.5%#12 | -77.2%#7 | -776.0%#12 | -100.6%#10 | — | — | 33.1%#5 | — |
| HBIO | $30M#9 | 0.7x#1 | 3.0x#5 | 0.3x#1 | -8.1%#11 | -357.1%#12 | -56.1%#9 | -564.4%#12 | -124.1%#9 | — | 45.7%#3 | — |
| ILMN | $29.0B#3 | 34.9x#3 | 10.9x#9 | 6.7x#7 | -0.7%#8 | 169.5%#1 | 18.6%#2 | 31.8%#1 | 23.4%#1 | 7#1 | 91.8%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3826). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice